Bio‑Rad EVP Evelyn Engelhardt Sells 89 Shares Amid Positive Market Sentiment as Company Eyes Asian Expansion and Medicare Reimbursement Efforts
Bio‑Rad insider sales show routine vesting, not a warning. Investors see strong Asia expansion plans and Medicare gains boosting share value.
3 minutes to read